Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK hypertension care up for review:

This article was originally published in Clinica

Executive Summary

The UK's National Institute for Health and Clinical Excellence (NICE) is preparing to undertake a review of its guidelines on the management of hypertension. The current guidelines, issued in August 2004, included a rejection of automated ambulatory blood pressure monitoring or home monitoring devices for routine use, on the basis that "their value has not been adequately established". Current policy also emphasises the need to consider assessing cardiovascular risk, covering testing for diabetes, hypertensive damage to the heart and kidneys and secondary causes of hypertension. A preliminary review of new data will be conducted in collaboration with the British Hypertension Society, given that it too will take into account the recently-concluded Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) as part of the development of its own guidelines.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT056521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel